RapidAI and AWS Deepen Partnership to Scale Clinical AI in Healthcare

RapidAI and AWS Deepen Partnership to Scale Clinical AI in Healthcare

What You Should Know: 

– RapidAI, the pioneer of deep clinical AI and a global leader in enterprise imaging, and Amazon Web Services (AWS) today announced a strengthened working relationship designed to accelerate the global adoption and scalability of deep clinical AI in healthcare.

– The expanded partnership focuses on co-development and strategic go-to-market alignment. It brings together the robust AI infrastructure and machine learning pipelines of AWS with RapidAI’s extensive deep clinical expertise and multimodal healthcare data, setting a new standard for intelligent healthcare infrastructure worldwide.

Building on AWS: Global Scalability with Rapid Edge Cloud

The foundation of this scalable global deployment is the Rapid Edge Cloud, which RapidAI will showcase at the AWS booth at RSNA 2025. The Rapid Edge Cloud is the market’s only cloud-native platform with on-premise capabilities, ensuring continuous and secure operation in any clinical environment. Built on AWS’s scalable global infrastructure, the platform currently supports hospitals in over 100 countries. This foundation enables seamless deployment of deep clinical AI while meeting the complex regional security, compliance, and data privacy requirements essential for global healthcare operations.

Dr. Rowland Illing, Global Chief Medical Officer and Director of Healthcare and Life Sciences at Amazon Web Services, emphasized the strategic importance of the collaboration: “RapidAI is advancing the frontier of clinical AI by pairing domain-specific intelligence with scalable cloud infrastructure. By building on AWS, they are helping hospitals accelerate AI-driven care delivery with confidence, resilience, and measurable clinical impact.”

Co-Developing the Next Generation of AI Solutions

The enhanced partnership includes co-developing advanced AI solutions and foundational model infrastructure to further accelerate clinical innovation. By combining AWS’s scalable AI pipelines with RapidAI’s deep clinical intelligence and disease-specific expertise, the two companies aim to deliver more adaptive and clinically validated AI.

The goal is to:

• Improve diagnostic precision
• Streamline clinical workflows
• Expand access to life-saving technologies worldwide

Karim Karti, CEO of RapidAI, highlighted the synergy: “AWS provides the trusted global infrastructure that allows RapidAI to deliver deep clinical AI at scale, securely, reliably, and without compromise. Together, we’re combining clinical depth with cloud scale, ensuring hospitals can harness powerful AI-driven insights no matter where they are in the world.”

Proven Clinical Depth: Impact on Workflow and Outcomes

RapidAI’s clinically validated Rapid Enterprise Platform powers advanced solutions such as Rapid Aneurysm, Lumina 3D, and Rapid Aortic. The company, a global leader in neurovascular deep clinical AI algorithms, is now expanding its solutions to include orthopedic, cardiovascular, and oncology applications. These solutions are transforming image-to-decision workflows, helping radiologists and clinicians work faster, collaborate seamlessly, and ultimately improve patient outcomes.

What You Should Know: 

– RapidAI, the pioneer of deep clinical AI and a global leader in enterprise imaging, and Amazon Web Services (AWS) today announced a strengthened working relationship designed to accelerate the global adoption and scalability of deep clinical AI in healthcare.

– The expanded partnership focuses on co-development and strategic go-to-market alignment. It brings together the robust AI infrastructure and machine learning pipelines of AWS with RapidAI’s extensive deep clinical expertise and multimodal healthcare data, setting a new standard for intelligent healthcare infrastructure worldwide.

Building on AWS: Global Scalability with Rapid Edge Cloud

The foundation of this scalable global deployment is the Rapid Edge Cloud, which RapidAI will showcase at the AWS booth at RSNA 2025. The Rapid Edge Cloud is the market’s only cloud-native platform with on-premise capabilities, ensuring continuous and secure operation in any clinical environment. Built on AWS’s scalable global infrastructure, the platform currently supports hospitals in over 100 countries. This foundation enables seamless deployment of deep clinical AI while meeting the complex regional security, compliance, and data privacy requirements essential for global healthcare operations.

Dr. Rowland Illing, Global Chief Medical Officer and Director of Healthcare and Life Sciences at Amazon Web Services, emphasized the strategic importance of the collaboration: “RapidAI is advancing the frontier of clinical AI by pairing domain-specific intelligence with scalable cloud infrastructure. By building on AWS, they are helping hospitals accelerate AI-driven care delivery with confidence, resilience, and measurable clinical impact.”

Co-Developing the Next Generation of AI Solutions

The enhanced partnership includes co-developing advanced AI solutions and foundational model infrastructure to further accelerate clinical innovation. By combining AWS’s scalable AI pipelines with RapidAI’s deep clinical intelligence and disease-specific expertise, the two companies aim to deliver more adaptive and clinically validated AI.

The goal is to:

• Improve diagnostic precision
• Streamline clinical workflows
• Expand access to life-saving technologies worldwide

Karim Karti, CEO of RapidAI, highlighted the synergy: “AWS provides the trusted global infrastructure that allows RapidAI to deliver deep clinical AI at scale, securely, reliably, and without compromise. Together, we’re combining clinical depth with cloud scale, ensuring hospitals can harness powerful AI-driven insights no matter where they are in the world.”

Proven Clinical Depth: Impact on Workflow and Outcomes

RapidAI’s clinically validated Rapid Enterprise Platform powers advanced solutions such as Rapid Aneurysm, Lumina 3D, and Rapid Aortic. The company, a global leader in neurovascular deep clinical AI algorithms, is now expanding its solutions to include orthopedic, cardiovascular, and oncology applications. These solutions are transforming image-to-decision workflows, helping radiologists and clinicians work faster, collaborate seamlessly, and ultimately improve patient outcomes.

Go to Source
2025-12-01 19:30

Except for the headline, this story has not been edited by Healthcare Central is published from a syndicated feed.